Ariad Pharmaceuticals Inc fka ARIA

[chazzzzz]

Remember Medarex ? Medx

My memory may be hazy about this but I remmember Medarex partnering with BMY for their melanoma drug ipilimuab or however you spell it. A few years ago MEDX ran up to $15 in anticipation for the conclusion of its phase 3 trial. After the data was released the FDA requested another trial due to safety concerns. Medx quickly sunk to $5 but its partner BMY continued on with the next trial. That is the trial the data was just released at ASCO.

Now during the course of events BMY eventually bought MEDX for $16.00 a share or 2.4 billion. They took control and magically the new melanoma drug looks to be approved. Medx could have never got that large of a trial off the ground without major help and BMY knew that but it came more cost effective just to buy the whole company considering they had a decent pipeline.

Which brings me to ARIA. There was at least a 100% in MEDX before the earlier ipilimimab study. Then the sudden destruction of wealth and then the sudden rise on the buyout. BMY had to know that the analysis of the study was good or they would have never bought them out.

Which brings us to MRK. Why would they amend the ARIA agreement in ARIA's favor knowing that ARIA could not survive without it ? MRK could have bought ARIA for $600 million no questions asked.
With MRK testing RIDA on so many indications you know that they must know something. The cost of all the RIDA trials has to be astronomical and at some point it must be more cost effective just to buy ARIA and its pipeline instead of paying out royalties.

I know the buyout is coming but I do not know at what price.

Any thoughts ?